Global Cell Expansion Market Report 2022: Rising Preference for Gene Therapy and Use of Biologics Drives Growth - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Cell Expansion Market by Product, by Cell Type, by Application, by End-User and by Region - Global Forecast to 2029" report has been added to ResearchAndMarkets.com's offering.

The global cell expansion market size is estimated to be USD 15.82 billion in 2021 and is expected to witness a CAGR of 12.85% during the forecast period. Increasing prevalence of chronic diseases, investment opportunities in cell-based therapy and biotechnology industry, rise in the use of the automated solutions for the purpose of cell expansion major factor that boosts the global market growth.

Also, the preference for gene therapy and use of biologics are some of the other factors that help in the growth during the forecast period. However, the risk of toxicity in animals and human beings in the course of research along with the ethical concerns with cell biology research are some of the factors hindering the market growth.

Based on the product, the global market is segmented into consumables, culture flasks and accessories and accessories, and instruments. In 2021, the consumables segment accounted for the largest revenue share owing to the rise in the demand for vaccines and other biopharmaceuticals, like biologic drugs for cancer treatment. However, the instruments segment is estimated to grow at the highest CAGR during the forecast period. This can be attributed to the automation of the bioreactors leading to high-efficiency performance.

By Cell Type

Based on the technique, the market is categorized into mammalian and microbial cells majorly. In 2021, the mammalian cells segment accounted for their high similarity to humans and hence can be used for various pharmacokinetic research. Human stem cells are having high demand and expected to post the highest growth rate in the forecast period due to the use of regenerative medicine and personalized medications in the medical research arena. The differentiated human cells have gained market share due to the demand rise in skin engineering.

By Application

Based on the application, the market is divided into biopharmaceutical, tissue culture, vaccine production, drug development. The biopharmaceutical segment was the highest revenue-grossing segment in 2021. This is due to the approval of biopharmaceutical product approval in the past years. Single-use technologies are gaining importance because of the increase in cell-based therapies. The vaccine segment will post the highest growth rate in the forecast period owing to the high adoption of cell-based therapy and regenerative medications among the patients.

By End-User

Based on end-user, biopharmaceuticals, research institutes, and cell banks are some of the important segments. The biopharmaceutical segment was the highest revenue grossing segment in 2021 due to the high preference for cell-based therapy in place of the traditional injectables for drug delivery. Inorganic growth is also taking place in the segment. Such as in 2021, Sartorius AG is in the process of acquisition of 50% of Biological Industries, which is into the cell culture manufacturing industry. The research institutes are expected to post the highest rate of growth and it may be attributed to a high number of researches that are happening in the biopharmaceutical field.

Market Segmentation

Cell Expansion Market, By Product (Revenue, 2021 - 2029, USD Billion)

• Consumables
  
  • Reagents, media, & serum
  • Other consumables
• Culture flasks and accessories
  
  • Tissue Culture Flasks
  • Bioreactor Accessories
  • Others

• Automated Cell Expansion Systems

• Cell Counters
• Centrifuges
• Bioreactors
• Others

Cell Expansion Market, By Cell Type (Revenue, 2021 - 2029, USD Billion)

• Mammalian Cells
• Human Cells
• Stem Cells
• Adult Stem Cells
• Induced Pluripotent Stem Cells
• Embryonic Stem Cells
• Differentiated Cells
• Animal Cells
• Microbial Cells
• Others

Cell Expansion Market, By Application (Revenue, 2021 - 2029, USD Billion)

• Biopharmaceuticals
• Tissue Culture & Engineering
• Vaccine Production
• Drug Development
• Gene Therapy
• Cancer Research
• Stem Cell Research
• Other Applications

Cell Expansion Market, By End-User (Revenue, 2021 - 2029, USD Billion)

• Biotechnology and biopharmaceutical companies
• Research Institutes
• Cell Banks
• Others

Blood Culture Tests Market, By Region (Revenue, 2021 - 2029, USD Billion)

North America

• US
• Canada

Europe

• Germany
• France
• UK
• Spain
• Italy
• Russia
• Rest of Europe

Asia Pacific

• China
• Japan
• Australia
• South Korea
• India
• Rest of APAC

Latin America

• Brazil
• Mexico
• Argentina
• Rest of LATAM

Middle East & Africa

South Africa

• Saudi Arabia
• Rest of MEA

Key Topics Covered:

1. Research Methodology

2. Introduction: Cell Expansion

3. Executive Summary

4. Market Dynamics

5. Market Environment Analysis

6. COVID-19 Impact Analysis: Cell Expansion Market

7. Market Analysis by Product

8. Market Analysis by Cell Type

9. Market Analysis by Application

10. Market Analysis by End user

11. Regional Market Analysis

12. North America Cell Expansion Market

11. Europe Cell Expansion Market

12. Asia Pacific Cell Expansion Market

13. Latin America Cell Expansion Market

14. MEA Cell Expansion Market

15. Competitor Analysis

16. Company Profiles

17. Conclusion & Recommendations

Companies Mentioned

• Thermo Fisher Scientific (U.S.)
• Lonza (Switzerland)
• Danaher (U.S.)
• Corning (U.S.)
• Becton
• Dickinson and Company (U.S.)
• Merck (Germany)
• STEMCELL Technologies Inc. (Canada)
• Terumo (Japan)
• Miltenyi Biotec (Germany)
• Sartorius Stedim Biotech (France)

For more information about this report visit https://www.researchandmarkets.com/r/s4yxkd

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900